NCT00980746View on ClinicalTrials.gov

Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

557

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

Eslicarbazepine acetate

Eslicarbazepine acetate tablets, scored to allow dose titration during the titration period.

DRUG

Placebo

oral route

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT00980746 - Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy | Biotech Hunter | Biotech Hunter